9 Meters Biopharma GAAP EPS of -$0.04 in-line

  • 9 Meters Biopharma press release (NASDAQ:NMTR): Q2 GAAP EPS of -$0.04 in-line.
  • As of June 30, 2022, the company's cash and cash equivalents totaled approximately $29.5M, compared to approximately $37.2M as of March 31, 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.